Aquestive Therapeutics (AQST) Stock Price, Quote, News & History | Benzinga

Aquestive Therapeutics Inc (AQST) Stock Price, Quote, News & History

AQSTNASDAQ

Trade with Public

Trade with Public

$4.26

0.040.95%

At close: Jun 16, 5:00 PM EST

$4.28

0.020.47%

After Hours: 7:34 PM EST

OverviewNews Earnings Events Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$4.20

Close

$4.26

Volume / Avg.

1.05M / 1.52M

Day Range

$4.20 - $4.30

52 Wk Range

2.93 - 7.55

Market Cap

$536.93M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

57

Short Interest

12.72%

Days to Cover

10.77

Recent Aquestive Therapeutics Inc News

What's Going On With Aquestive Therapeutics Stock After FDA Update For Lead Allergic Treatment?

Aquestive received an FDA rejection for its allergy film due to safety and use issues. The company plans new studies and targets resubmission in 2026.

Vandana Singh

Bad News For Competitor Turns Into Big Win For ARS Pharma Stock

ARS Pharmaceuticals Inc. stock rose Friday as FDA identified deficiencies in rival Aquestive's application, delaying potential competition.

Vandana Singh

Aquestive Stock Slides After FDA Flags Issues With Allergy Drug Application

Aquestive Therapeutics shares fall after the FDA flags deficiencies in its Anaphylm allergy drug application, raising approval delay concerns despite the review remaining active.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-43.84M

Investing Cash Flow (TTM)

-479.00K

Financing Cash Flow (TTM)

86.39M

Free Cash Flow (TTM)

-44.32M

Capital Expenditure (TTM)

-479.00K

Net Change in Cash (TTM)

42.08M

Analyst Rating and Forecast

4.5

Strong Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$462.25M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

9.54

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-14.45%

Earnings Yield % (FWD)

-11.37%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.27

Company Debt

Total Debt

$38.76M

LT Debt

$25.10M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$28.00K

Total Cash

$110.73M

Debt to Equity

-

Issuance of Debt (TTM)

-$28.00K

Repayment of Debt (TTM)

-$28.00K

Key Statistics

Open

$4.20

Close

$4.26

Volume / Avg.

1.05M / 1.52M

Day Range

$4.20 - $4.30

52 Wk Range

2.93 - 7.55

Market Cap

$536.93M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

57

Short Interest

12.72%

Days to Cover

10.77

About

Sector

Health Care

Industry

Pharmaceuticals

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous Sys...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Aquestive Therapeutics (AQST) stock?

A

You can purchase shares of Aquestive Therapeutics (NASDAQ:AQST) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Aquestive Therapeutics (AQST) competitors?

A

There are no as such competitors for Aquestive Therapeutics.

Q

What is the forecast, or price target, for Aquestive Therapeutics (AQST) stock?

A

Aquestive Therapeutics has a consensus price target of $9.90.

Q

What is the current price for Aquestive Therapeutics (AQST)?

A

The stock price for Aquestive Therapeutics (NASDAQ: AQST) is $4.28 last updated June 16, 2026 at 7:34 PM EDT.

Q

Does Aquestive Therapeutics (AQST) pay a dividend?

A

There are no upcoming dividends for Aquestive Therapeutics.

Q

When is Aquestive Therapeutics (NASDAQ:AQST) reporting earnings?

A

Aquestive Therapeutics does not have any upcoming earnings scheduled.

Q

Is Aquestive Therapeutics (AQST) going to split?

A

There is no upcoming split for Aquestive Therapeutics.

Q

What sector and industry does Aquestive Therapeutics (AQST) operate in?

A

Aquestive Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.